Jingfeng Pharmaceutical(SZ:000908) Sou Hu Cai Jing·2025-08-14 08:44Company Overview - Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with key products including various injections and capsules, many of which are unique in the market and covered by national health insurance [2]. Financial Performance - For Q1 2025, the company reported revenue of 100 million yuan, a year-on-year decrease of 0.46%, and a net loss of approximately 11.90 million yuan, representing a significant year-on-year decline of 960.04%. The gross profit margin stood at 66.62% [3]. Market Position - As of August 14, ST Jingfeng's closing price was 5.77 yuan, with a rolling price-to-earnings (PE) ratio of 35.87 times. The company's total market capitalization is 5.076 billion yuan. In comparison, the average PE ratio for the chemical pharmaceutical industry is 66.15 times, with a median of 35.63 times, placing ST Jingfeng at the 91st position in the industry ranking [1][3]. Capital Flow - On August 14, ST Jingfeng experienced a net outflow of 12.84 million yuan in principal funds, continuing a trend of outflows over the past five days, totaling 19.22 million yuan [1].